Accelerates healing | Better results

Patented low intensity shock wave technology for Advanced Wound Care

62 yr old DFU patient after 4 SoftWave sessions

MECHANISMS OF ACTION

• Modulates inflammation
• Increased blood supply
• Stimulates cytokines and growth factors
• Promotes Angiogenesis
• Wound epithelialization
• Tissue Regeneration

Fast healing
Non-invasive and safe
Well tolerated
Fast treatment times
Easy to use
FDA Cleared for DFU
Less costly than HBOT, NPWT & CPT

Let the healing begin one softwave at a time

Find a Provider Contact Us to Learn More

SoftWave triggers biological responses

SoftWave produces a biological response that accelerates angiogenesis and revascularization which promotes faster wound healing.

Click on the above image to access our White Paper

SoftWave initiates a more rapid and effective healing phase.

It is thought to work by:

Increasing the blood flow to the wounded area
Stimulating the neovascularization and growth factors
Modulating the inflammatory process
Stimulating osteoclasts and fibroblasts to rebuild injured tissue
Facilitating resorption of calcification in tendons and ligaments
Stimulating the migration of resident stem cells

RESEARCH

Extra Corporeal Shock Wave Therapy (EWST)

Extra Corporeal Shock Wave Therapy (EWST) has been widely used to treat a wide range of conditions, including complex and chronic non-healing soft tissue wounds with different etiologies, such as DFUs, peripheral arterial diseases, venous leg ulcers, and pressure ulcers.

ESWT has been demonstrated to positively impact the four stages of wound healing:

Inflammation: Low-energy shock waves can lower the pro-inflammatory response, induce the anti-inflammatory profile in macrophages, and alter the expression of cytokines and chemokines. Shock waves also reduce leukocyte and macrophage infiltration in isograft tissue and decrease the corresponding macrophage-derived inflammatory protein response.
Infection: Shock waves have a bactericidal effect and can reduce the bacterial burden of the wound. They also increase the number of microvessels and improve the delivery of antibiotics to an infected wound.
Apoptosis and necrosis: Shock wave treatment can decrease cellular apoptosis and reduce the necrosis of wounds.
Remodeling and neovascularization: Shock wave treatment can accelerate granulation and re-epithelialization and reduce scar formation. It also increases overall blood circulation and stimulates cutaneous and muscular microcirculation.

EWST is an adjunctive therapy that can be combined with standard wound care therapies.

ESWT is an evidence-based, non-invasive, convenient treatment for chronic wounds, including DFUs. One study found that using ESWT to treat chronic wounds resulted in nearly three-fourths (74.03%) of wounds closing and not reappearing in the same location.

Moreover, a meta-analysis that looked at five randomized studies implementing EWST across multiple types of wounds, including burns and DFUs, found a 20% absolute efficacy advantage for ESWT relative to control treatments and achievement of 50% of the performance goals outlined for ESWT effectiveness.

SoftWave's patented applicator is the difference

The SoftWave TRT patented, unfocused applicator design makes it possible to spread energy to a large treatment area to stimulate the body’s natural healing process and without microtrauma.

Powerful treatment area of 7cm x 12cm

SoftWave produces a TRUE shock wave that accelerates wound healing

SoftWave Treatment offers patients a more convenient and cost effective healing option

Extracorporeal shock wave therapy (ESWT) can effectively shorten the healing period and reduce the ineffectiveness of diabetic foot ulcer treatment by 4.8-fold.
ESWT is not only superior to standard wound care, but also significantly better than hyperbaric oxygen therapy as an adjuvant treatment.

Huang et al (2019). Extracorporeal Shock Wave Therapy for Treating Foot Ulcers in Adults With Type 1 and Type 2 Diabetes: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Canadian Journal of Diabetes, 44 (2020) 196-204

SoftWave Therapy

SoftWave therapy is typically a 10-minute treatment performed once a week for 6-8 weeks. SoftWave produces an unfocused shock wave which has the patented advantage of distributing maximum energy to a wide and deep area. This makes for reduced treatments and better outcomes.

Reimbursement Pathway with CPT Codes 0512T and 0513T

CONVENIENT

Fast and easy to use

Used in an office/wound clinic/outpatient setting

Mobile unit fits seamlessly within wound care clinic

Does not require a sterile environment

Average treatment time is less than 10 minutes

Once-a-week treatment

EFFECTIVE

Faster wound healing than standard of care

Non-invasive

Adjunct therapy can be used alone or in combination with other Advanced Wound Care

Decreases complications and amputation rates

PROVEN

FDA cleared to treat DFUs

Reimbursement Pathway with CPT codes 0512T and 0513T

Less costly than HBOT, NPWT, Skin Substitutes

TRUSTED

Used at leading national and international research and medical centers as well as professional sports organizations such as: